LUCD · Lucid Diagnostics Inc
United States · RS rating 6 · As of 2026-11-03
| Price | 0.41 USD |
|---|---|
| 1-day change | +0.7% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 11 / 6 / 14 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 3 / 16 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | +24.2% |
| Distance from 52-week high | +72.2% |
| Market cap (USD) | $185.7M |